Assessing brain biochemistry in the early evaluation of dementia: can we afford the improved diagnostic accuracy obtained by incorporating cerebral metabolic data acquired with positron emission tomography into the clinical work-up?
Silverman
Daniel H S
DH
Department of Molecular and Medical Pharmacology, School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA. dsilver@ucla.edu
Phelps
Michael E
ME